ADA June 2016, Exenatide QW - Poster

Change in HbA1c, weight and blood pressure in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide once weekly (QW) audit

R M Gifford1, J Joharatnam2, K Darzy2, A Helmy3, E McKeever3, E Brennon4, R Harper4, K Sands5, D Barnes6, R E Ryder7 and K A Adamson1 on behalf of ABCD Exenatide QW Audit contributors

1NHS Lothian

2East & North Hertfordshire NHS Trust

3Erne South West Acute Hospital

4The Ulster Hospital

5South West Yorkshire Partnership NHS Foundation Trust

6Maidstone And Tunbridge Wells NHS Trust

7Sandwell & West Birmingham NHS Trust

Discipline

Diabetes
Resource taxonomy
Audit Posters
Clinical taxonomy
Treatments for diabetes Type 2 diabetes mellitus
Listing status
Archived

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd